Please login to the form below

Not currently logged in
Email:
Password:

Vansen Pharma appoints new president and CEO

Ahmad Doroudian was CEO of Merus Labs International

Vansen Pharma has appointed Dr Ahmad Doroudian as its new president and CEO.

He joins from Merus Labs International where he serves as CEO and vice chairman, following an extensive career in life sciences.

This includes founding and leading PanGeo Pharma as CEO as well as senior roles at Neurokine Pharmaceuticals, Rayan Pharma and ABF Pharmacy – a group of retail pharmacies.

Vansen also announced a new chief financial officer in the form of Moira Ong. She has more than 16 years' experience in accounting and consulting and most recently served with Dr Doroudian at Merus as VP of finance.

6th March 2014

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Life Healthcare Communications

Life is a creative communications agency offering multi-channel solutions for the healthcare industry. We use a storytelling approach to turn...

Latest intelligence

Diversity in clinical trials: looking back at our 2021 blogs
In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021...
What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...